Evidence map›Paper›PMID 39372633›Full record

ArticleIndian journal of nephrology

Clinical Transplant Kidney Function Loss Due to Small Intestinal Bacterial Overgrowth.

Tomoo Kise, Masatsugu Uehara

Abstract readCase Reports
In one paragraph

Article in Indian journal of nephrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tomoo KiseDivision of Paediatric Nephrology, Okinawa Prefectural Nanbu Medical Centre, Children's Medical Centre, Haebaru, Japan.
Masatsugu UeharaDivision of Paediatric Nephrology, Okinawa Prefectural Nanbu Medical Centre, Children's Medical Centre, Haebaru, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small intestinal bacterial overgrowth (SIBO) is a clinical syndrome involving gastrointestinal symptoms caused by the presence of excessive bacteria in the small intestine. SIBO often leads to diarrhea and poses diagnostic and treatment challenges. Here, we report about a renal transplant recipient who experienced diarrhea-induced hypovolemic shock due to SIBO, necessitating the reintroduction of dialysis, and aim to provide insights to aid health-care providers in diagnosing and managing severe diarrhea in this specific patient group. A 14-year-old boy, who had undergone renal transplantation at the age of 2 years, experienced severe, recurring diarrhea leading to hypovolemic shock. The patient underwent volume loading and continuous hemodiafiltration. Upper gastrointestinal endoscopy findings suggested Whipple's disease. Antibiotics were initiated; however, the diarrhea did not improve. Examinations for infectious enteritis and food allergies yielded negative results. The diarrhea improved with rifaximin (RFX), but recurred repeatedly after its discontinuation. Antibiotic rotation, wherein RFX, amoxicillin hydrate and potassium clavulanate, ciprofloxacin, and RFX were administered in this order for 4 weeks each, improved the diarrhea. A lactulose breath test performed immediately before the second RFX course yielded negative results. The patient's condition was diagnosed as SIBO based on the clinical course, although the diagnostic criteria were not met. SIBO should be considered in cases of gastrointestinal symptoms in patients with transplanted kidneys. Antibiotic rotation should be considered for SIBO treatment in immunosuppressed patients.

Indexed as

Antibiotic rotationimmunosuppressionpost-kidney transplant patientsevere diarrheasmall intestinal bacterial overgrowth

Identifiers

PMID39372633
PMCPMC11450811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.